Skip to main content
H.R. 7174 118th Congress House

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Introduced: January 31, 2024 Introduced by: Gregory F. Murphy Republican · North Carolina See on congress.gov
Health Health care costs and insuranceMedicarePrescription drugs
Sign in to write a letter

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Jan 31, 2024
Introduced in House
Jan 31, 2024
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 17, 2024

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Lobbying activity 7

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 7 filings →
 Cosponsors 17
All 17 Democratic 2 Republican 14
R
Miller-Meeks, Mariannette
Iowa · Dec 18, 2024
 R
James, John
Michigan · Dec 5, 2024
 R
Tenney, Claudia
New York · Dec 4, 2024
 R
McCormick, Richard
Georgia · Nov 18, 2024
 R
Dunn, Neal P.
Florida · Oct 1, 2024
 R
Valadao, David G.
California · Sep 18, 2024
 D
Gottheimer, Josh
New Jersey · Sep 6, 2024
 R
Allen, Rick W.
Georgia · Aug 16, 2024
 R
Crenshaw, Dan
Texas · Aug 16, 2024
 R
Kean, Thomas H.
New Jersey · May 14, 2024
 R
Malliotakis, Nicole
New York · May 14, 2024
 R
Yakym, Rudy
Indiana · May 8, 2024
Wenstrup, Brad
· Apr 18, 2024
 R
Curtis, John R.
Utah · Feb 14, 2024
 R
Miller, Carol D.
West Virginia · Feb 14, 2024
 D
Davis, Donald G.
North Carolina · Jan 31, 2024
 R
Guthrie, Brett
Kentucky · Jan 31, 2024
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.. 118th Congress. Open America. https://openamerica.io/bill/118-HR-7174/
MLA
"H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-7174/.
Bluebook (legal)
H.R. 7174, 118th Cong. (2026), https://openamerica.io/bill/118-HR-7174/.
Markdown link
[H.R. 7174: To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.](https://openamerica.io/bill/118-HR-7174/)
Report a problem